Gastrointestinal Cells TRIZ Cases

Using TNAP recognized by the STRO-3 antibody, this case shows selective enrichment of adult multipotential cells for isolation and expansion.

A stromal cell layer and xeno-free hydrogel help pluripotent stem cell intestinal organoids mature with better engraftment and clinical suitability.

Humanized immune system mice support intestinal organoids with immune cells, enabling lymphoid-like structures and functional M cell differentiation.

Cryopreservation of human biopsy tissue enables later thawing and organoid culture establishment, extending storage and global shipment.

Directed differentiation of definitive endoderm uses Wnt and retinoic acid patterning to build human esophageal organoids for disease modeling.

A 3D scaffold guides self-renewing cells to form organoids with reproducible crypt location, size, number, and tissue-like morphology.

ETV2-expressing endothelial cells pre-vascularize islets and β-cell organoids to improve engraftment, survival, and glycemic control.

A rollable scaffold with controlled seeding regions forms cavity-free tubular tissue, helping prevent leakage, dissection, and aneurysm risk.

TGFB1 pre-treatment primes intestinal organoids into a regenerative state, improving GI tissue engraftment and repair potential.

A 3D bioprinted intestinal tissue model improves prediction of drug absorption, metabolism, and toxicity beyond standard 2D and animal models.